The Society of Nuclear Medicine and Molecular Imaging, SNMMI, will hold its 2018 Annual Meeting from June 23 to 26 in Philadelphia. Over 5,600 attendees from more than 60 countries are expected to attend.  In the area of Oncology and Therapy, NET physicians will discuss the basic principles of peptide receptor radionuclide therapy, PRRT, in neuroendocrine tumors, examine various approaches of treatments / schema with PRRT, and describe utilization and differences of PRRT applications.  Targeted PET in Oncology is another of the Continuing Education Sessions.

For more information, click here: http://www.snmmi.org/AM2018.